Miranda Toledano has joined H.C. Wainwright’s healthcare investment banking team where she will focus on building out the firm’s footprint across Europe and Israel.
Ms. Toledano moved to Tel Aviv last month after 14 years in New York. She was previously EVP of corporate development for Sorrento Therapeutics (NASDAQ:SRNE) and president of LA Cell, Sorrento’s joint venture with City of Hope.
Prior to joining Sorrento, Ms. Toledano had 18 years of principal investment, financing and strategic advisory experience in the biopharmaceutical sector, including head of healthcare investment banking at MLV & Co., now an FBR company, where she completed more than 110 IPOs and follow on equity offerings, totalling more than $4-billion.
